$Esperion Therapeutics (ESPR.US)$Esperion initiated with an Overweight at Cantor Fitzgerald - TipRanks.com BELOW is a Detailed research report that should convince readers to have a portion of their investment portfolio in Esperion. This is not a pump article, please take the time to read and fact check. This $2 stock will be $20+ by 2027. Esperion anticipates billions in Revenues. Es...
Esperion Therapeutics股票討論
Es...
讓我們把它推上月球,夥計們!
但爲什麼????認真地..
暫無評論